dx 8951 has been researched along with sufentanil in 1 studies
Studies (dx 8951) | Trials (dx 8951) | Recent Studies (post-2010) (dx 8951) | Studies (sufentanil) | Trials (sufentanil) | Recent Studies (post-2010) (sufentanil) |
---|---|---|---|---|---|
73 | 18 | 15 | 2,156 | 956 | 678 |
Protein | Taxonomy | dx 8951 (IC50) | sufentanil (IC50) |
---|---|---|---|
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 4.5 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0023 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0014 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0023 | |
Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | 2.077 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for dx 8951 and sufentanil
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |